| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairperson | Chief Executive Officer
1 company
Garipalli Vivek serves as an Executive Chairperson at CLOV. Across recent SEC filings that breaks down to 4 buys and 0 sells. Those positions are worth an estimated $4.8M at current prices.
Historically, Garipalli Vivek's trades have earned a strong insider score of 83/100 across 4 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +58.6%.
The biggest single holding is CLOV (~$4.8M). Net of sales, the recent Form 4 record there shows accumulation of 1,856,247 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | CLOV Clover Health Investments, Corp. /de | - | Buy | 446,980 | $2.23 | $998,996.60 | +31.7% | +19.7% | +118.3% | |
| Aug 9, 2024 | CLOV Clover Health Investments, Corp. /de | - | Buy | 531,700 | $1.88 | $999,596.00 | +60.6% | +97.3% | +17.2% | |
| Jun 17, 2024 | CLOV Clover Health Investments, Corp. /de | - | Buy | 877,567 | $1.14 | $1,000,426.38 | New | +166.1% | +146.1% |